Log In
BCIQ
Print this Print this
 

rhEPO-Fc (Uni-EPO-Fc)

  Manage Alerts
Collapse Summary General Information
Company Uni-Bio Science Group Ltd.
DescriptionLong-acting human erythropoietin-Fc fusion protein
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Fusion protein
Latest Stage of DevelopmentPhase I
Standard IndicationAnemia
Indication DetailsTreat anemia associated with renal diseases, cancer related therapies, or surgical blood loss; Treat anemia caused by renal diseases, chemotherapy and HIV treatment
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today